Synthego Prevails In Patent Appeal Confirming Agilent CRISPR Patents Are Invalid – Longview News-Journal
Synthego Prevails In Patent Appeal Confirming Agilent CRISPR Patents Are Invalid Longview News-Journal
In: PATENT NEWS
Synthego Prevails In Patent Appeal Confirming Agilent CRISPR Patents Are Invalid Longview News-Journal
In: PATENT NEWS
Yuhan secures US patent for lung cancer drug lazertinib, blocking copycats koreabiomed.com
In: PATENT NEWS
AB Science announces issuance of a Canadian patent protecting the composition of matter of AB8939, including its use in the treatment of acute myeloid leukemia, with protection until 2036 GlobeNewswire
In: PATENT NEWS
Europe’s Leading Patent Law Firms — 2025 ranking Financial Times
In: PATENT NEWS
Cyclopharm secures maximum US patent extension for Technegas to 2031 Biotech Dispatch
In: PATENT NEWS
Nura Labs Files Revolutionary Patent: AI-Powered Wallet Solves the $180 Billion Crypto Staking Complexity Crisis The Manila Times
In: PATENT NEWS
Fed. Circ. Backs PTAB Invalidation Of Agilent CRISPR Patents Law360
In: PATENT NEWS
Thirty attorneys from global law firm Greenberg Traurig, LLP are recognized in Managing Intellectual Property magazine’s 2025 edition of “IP Stars …
In: PATENT NEWS
US Appeals Court Confirms Patent Validity of Acadia’s Parkinson’s Medication Insider Monkey
In: PATENT NEWS
US Appeals Court Confirms Patent Validity of Acadia’s Parkinson’s Medication Yahoo Finance
Designed by Industrial Action
Copyright © 2025 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION